Skip to main content

Table 2 BAG3 protein expression and clinicopathological features of colorectal cancer patients

From: Bcl-2-associated athanogene 3(BAG3) is associated with tumor cell proliferation, migration, invasion and chemoresistance in colorectal cancer

Clinicopathological feature

cases

BAG3 expression

χ2

P value

0–5 scores Low, n (%)

6–12 scores High, n (%)

Gender

4.284

0.038

 male

47

34 (37.7)

13 (14.4)

 female

43

22 (24.4)

21 (23.3)

Age

0.379

0.538

 ≤ 65

35

20 (22.3)

15 (16.6)

 > 65

55

35 (38.8)

20 (22.3)

Tumor size (cm)

11.328

0.001

 ≤ 5

47

37 (42.0)

10 (11.4)

 > 5

41

18 (20.4)

23 (26.2)

Tumor differentiation

4.600

0.100

 I

5

5 (5.6)

0 (0)

 II

49

32 (35.6)

17 (18.9)

 III

36

19 (21.1)

17 (18.9)

 IV

0

0 (0)

0 (0)

TNM stage

2.531

0.470

 I

8

5 (5.6

3 (3.4)

 II

47

33 (37.1)

14 (15.7)

 III

32

17 (19.1)

15 (16.9)

 IV

2

1 (1.1)

1 (1.1)

Lymph node metastasis

0.175

0.096

 Negative

55

38 (42.7)

17 (19.1)

 Positive

34

18 (20.2)

16 (18.0)

  1. Note: There are 2 cases with no available tumor size, 1case with no available TNM stage and lymph mode metastasis, these cases are missing in the origin clinical follow-up data table which is provided by the Shanghai Outdo Biotech Company